Question 1

What are the potential risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Absolute Bioavailability of BMS-626529 After Oral and Intravenous Dosing clinical trial (NCT02805556). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my health be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Absolute Bioavailability of BMS-626529 After Oral and Intravenous Dosing clinical trial (NCT02805556). Contact the study team or your healthcare provider for specific answers.

Question 3

What should I expect during the IV administration of the drug?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Absolute Bioavailability of BMS-626529 After Oral and Intravenous Dosing clinical trial (NCT02805556). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any long-term effects I should be aware of after participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Absolute Bioavailability of BMS-626529 After Oral and Intravenous Dosing clinical trial (NCT02805556). Contact the study team or your healthcare provider for specific answers.

Question 5

How does this study contribute to understanding HIV treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Absolute Bioavailability of BMS-626529 After Oral and Intravenous Dosing clinical trial (NCT02805556). Contact the study team or your healthcare provider for specific answers.

What this study is about